Generated by AI
Emergent BioSolutions Inc. is a life sciences company focused on preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats. Its current business centers on medical countermeasures and specialty products, including public health protection tools used by government agencies, healthcare providers, and other institutional customers. The company’s portfolio includes commercial products, medical countermeasure products, and services, with an emphasis on areas such as opioid overdose reversal, smallpox and anthrax preparedness, and contract development and manufacturing support. Emergent BioSolutions plays a specialized role in the healthcare and biodefense markets by supplying products and services designed to support emergency readiness and public health response across the United States and international markets.
Website300 Professional Drive
Gaithersburg, MD, 20879
United States
The latest articles about EBS.
Emergent BioSolutions faces margin pressure, lowered FY26 guidance, and weak profitability despite cost cuts. Learn more about EBS stock here.
Summary of Nov 3's posts. Generated by AI.
Summary of Nov 3's posts. Generated by AI.
Summary of Aug 30's posts. Generated by AI.
Summary of Oct 30's posts. Generated by AI.
Investors talking about EBS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.